What Cellendes GmbH does

Cellendes GmbH is a privately held German life science company headquartered in Reutlingen that develops and commercializes the 3-D Life product line, an integrated system of biomimetic hydrogels for 3-D cell culture. Founded in 2009 by Dr. Brigitte Angres and Dr. Helmut Wurst as a spinoff of the NMI Natural and Medical Sciences Institute at the University of Tübingen, the company's core platform relies on thioether and thiol-ene covalent crosslinking chemistry that forms hydrogels at ambient temperature and physiological pH, enabling tunable stiffness (50 Pa to 8 kPa), defined mesh size, and customizable biomimetic features including RGD and GFOGER-3 cell-adhesion peptides and MMP- or hyaluronidase-cleavable crosslinkers. The portfolio spans Ready-to-Go pre-configured kits, Ready-to-Design modular kits, ToLuminate photo-inducible hydrogels for bioprinting, individual polymers (SG-Dextran, SG-PVA, FG-PVA, FG-Dextran, N-Dextran), crosslinkers (PEG-Link, CD-Link, HyLink, CD-HyLink), peptides, conjugation buffers, and accessory reagents (AgaFloat, Dextranase, Thioglycerol).

Cellendes sells primarily through a direct-to-customer e-commerce storefront at cellendes.com and through international distribution partners, with standardized EUR pricing per unit SKU (roughly €17–€490) and temperature-controlled shipping (ambient or dry ice) from its Reutlingen facility. The company's primary customer segment is academic and research institutions conducting basic 3-D cell culture, drug development, and biomedical engineering work; pharmaceutical/biotech and biomedical engineering segments are secondary. Marketing emphasizes scientific credibility through an extensive protocol library, peer-reviewed publications spanning 13+ years, and conference participation. The firm is founder-owned, with no disclosed institutional investors, funding rounds, or acquisitions. Recent product activity — including the Hyaluronic Acid integration (2022), GFOGER-3 Peptide (2024), AgaFloat (2025), and ToLuminate Photogels (2026) — indicates a sustained cadence of platform extensions targeting both traditional 3D cell culture and the emerging bioprinting market.

Name

Cellendes GmbH

Legal name

Cellendes GmbH

Website

https://cellendes.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Cellendes GmbH is a privately held German life science company that develops and sells the 3-D Life product line of biomimetic hydrogels and reagents for 3-D cell culture, serving academic researchers, pharmaceutical/biotech laboratories, and biomedical engineering groups primarily across Europe via direct e-commerce and distributors.

Ownership category

akta.pro rank

Product category

3D Cell Culture Reagents

NAICS

Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)

SIC

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)

akta.pro primary industry

Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)

Keywords

• 3D cell culture
• Biomimetic hydrogels
• Hydrogel kits
• Cell adhesion peptides
• Life science reagents

Headquarters

HQ city

Reutlingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales (Direct and Distributor): Sale of 3-D Life Hydrogel kits, individual components (polymers, crosslinkers, peptides), and accessories through direct online shop and international distribution partners. Products are sold as unit kits with various sizes and configurations.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Cellendes GmbH develops and manufactures the 3-D Life Hydrogel system, an integrated portfolio of biomimetic hydrogels, crosslinkers, polymers, and cell-adhesion peptides for controlled 3D cell culture and tissue engineering. The product range spans ready-to-go and ready-to-design hydrogel kits (dextran-, PVA-, and hyaluronic-acid-based), photo-inducible ToLuminate hydrogels, cell-adhesion peptides (RGD, GFOGER-3, scrambled RGD), and auxiliaries (dextranase, thioglycerol, conjugation buffers, AgaFloat), enabling customers to assemble hydrogels with tunable stiffness, mesh size, degradability, and biomimetic functionality at room temperature.

Product overview

Cellendes GmbH offers the 3-D Life product line, an integrated system of biomimetic hydrogels for 3D cell culture. The product portfolio consists of Ready to Go (RTG) pre-configured hydrogel kits, Ready to Design (RTD) flexible hydrogel kits, and individual components. Key product lines include: PVA Hydrogels (stable for long-term cultures), Dextran Hydrogels (enzyme-degradable for cell recovery), and Hyaluronic Acid Hydrogels (biomimetic for tissue models). The ToLuminate Photogels sub-line offers photo-inducible hydrogels using thiol-ene chemistry. Supporting products include cell adhesion peptides (RGD Peptide, GFOGER-3 Peptide), crosslinkers (PEG-Link, CD-Link, HyLink, CD-HyLink), thioreactive polymers (SG-PVA, SG-Dextran, FG-PVA, FG-Dextran, N-Dextran), conjugation buffers, and accessory reagents (Dextranase, AgaFloat). The system enables controlled design of cell environments for applications in basic research, drug development, and biomedical engineering.

Differentiator

Problem solved

Functional benefit

Brands

• 3-D Life: Biomimetic hydrogel product line for 3D cell culture, including hydrogel kits, components, crosslinkers, and peptides.
• ToLuminate

Products and services

• 3-D Life Hydrogel System
• Ready to Go Hydrogels (RTG Kits)
• Ready to Design Hydrogels (RTD Kits)
• ToLuminate Photogels
• ToGro Hydrogel
• Cell Adhesion Peptides
• Auxiliaries and Reagents
• GMP Hydrogel Product Line

Quantifiable outcome

• Reduced ROS generation compared to methacrylate-based hydrogels (e.g., GelMa)
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• NMI Natural and Medical Sciences Institute at the University of TübingenfoundationalStrategic or Co-development PartnerCellendes was founded in 2009 as a spinoff from the NMI. The 3-D Life Technology was co-developed by founders Dr. Angres and Dr. Wurst at NMI since 2007. The NMI connection provides ongoing academic collaboration and research partnerships.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Advanced BioMatrix: Advanced BioMatrix sells collagen, hyaluronic acid, and other ECM-derived and synthetic hydrogels for 3D cell culture and tissue engineering. It is a directly comparable peer in biomaterial reagents for research applications.
• QGel Sciences: QGel develops synthetic, animal-free hydrogels for organoid and 3D cell culture applications. It directly competes with Cellendes' 3-D Life platform on synthetic, biomimetic, animal-free positioning.
• Cell Guidance Systems: Cell Guidance Systems offers PODS, hydrogels, and reagents for 3D cell culture and organoid research. It is a directly comparable niche peer to Cellendes in the biomimetic reagent space.
• PeptiGel Design Technologies: PeptiGel designs synthetic, self-assembling peptide hydrogels for 3D cell culture and bioprinting. It is a direct peer competing on synthetic, animal-free hydrogel chemistry with applications in drug discovery and tissue engineering.
• AMSBIO: AMSBIO distributes and develops a range of hydrogels, scaffolds, and 3D culture reagents. It is a directly comparable peer offering competing products to academic and biotech 3D cell culture researchers.
• BICO (CELLINK): BICO, operating the CELLINK brand, sells bioinks and hydrogels (including GelMA-based systems) for 3D bioprinting and cell culture. It is a direct peer to Cellendes in the photo-inducible and bioprinting hydrogel space that Cellendes' ToLuminate targets.

Broad incumbents

• Bio-Techne: Bio-Techne supplies Cultrex basement membrane extracts and engineered hydrogels for 3D culture through its life science reagents portfolio. It is a broad incumbent comparable to Cellendes in serving researchers building organoids and tissue models.
• Corning Life Sciences: Corning is the maker of Matrigel and PuraMatrix, the dominant animal-derived and synthetic hydrogels for 3D cell culture. It is the broadest incumbent competing with Cellendes across academic and pharma customers with deeper distribution and brand recognition.
• Thermo Fisher Scientific: Thermo Fisher offers Geltrex and other 3D culture matrices through its life science tools portfolio. As a broad incumbent, it competes with Cellendes by bundling hydrogels into larger research consumables contracts.

Emerging players

• OrganaBio: OrganaBio supplies cell culture reagents and hydrogels for regenerative medicine and 3D tissue models. It is an emerging peer with overlapping customer segments in pharma/biotech tissue model applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cellendes-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellendes GmbH